---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "k1maI8rvwONllyN5PGbHTT/PDW3ZujgKgn8ksDiGJKokzaJXfTiQR5AnhjizCgNZNfIsDVxsfasI88jeWoCoV4te1qHaU5T+UJ/3EveaVq51r5ngThkaV4+oB65bcqmUgGHgalFfSg13QDgQXbWSW2FvNh+Vks0FZnu6cRaP80aiTU5JtSTfQYveN5j4EnfMXu26IbvRC7oQ1SyH0epXdCUIZw8F+EIs/xA3K3EZGkuvufhD1M5zPp1Ym5S1oYxZ1QinzrtwYmdN41KmaPq1pqvhQq05YQZRE+F/XzwBwqnjbuDc7zTWQO6kdFmLt1Ll;gVN8jy6UACUgpNZfqoT5xA=="
---

